- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06586138
Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Test (STAYAWAKE)
Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Tests Results
The predictors of objective impaired alertness assessed by Maintenance of Wakefulness Tests (MWT) are poorly understood. Identifying such predictors are essential from a clinical point of view and from a pathophysiological perspective, to better understand the determinants of residual Excessive Daytime Sleepiness (EDS) and the complex link between subjective and objective impairments.
Also, the objective of this study is to describe psychological but also sociological and professional factors associated with Maintenance of Wakefulness Tests results.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Pierre TANKERE, MD
- Phone Number: +33 0472071929
- Email: pierre.tankere01@chu-lyon.fr
Study Contact Backup
- Name: Laure PETER-DEREX, MD
- Phone Number: +33 0472071929
- Email: laure.peter-derex@chu-lyon.fr
Study Locations
-
-
-
Lyon, France, 69004
- Recruiting
- Service de Médecine du Sommeil - Hopital Croix Rousse
-
Contact:
- Pierre TANKERE, MD
- Phone Number: +33 0472071929
- Email: pierre.tankere01@chu-lyon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult (i.e. age ≥ 18 y.o)
- referred for Maintenance of Wakefulness test at Lyon University hospital (HCL - Croix Rousse Hospital)
Exclusion Criteria:
- do not consent
- unable to answer the questionary
- cognitive impairments
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Maintenance of Wakefulness Test
Consecutive patients referred for Maintenance of Wakefulness test at the center for Sleep Medicine in Lyon University hospital (HCL - Croix Rousse Hospital)
|
Patient completed STAI Scale in the 24 hours before Maintenance of Wakefulness Test during the hospitalization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State-Trait Anxiety Inventory (STAI) score
Time Frame: baseline
|
STAI ((State-Trait Anxiety Inventory) scale is a psychological inventory of 20 self-report items on a 4-point scale.
Minimum Score is 20 and maximum score is 80.
|
baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL24_0658
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Narcolepsy
-
TakedaRecruitingNarcolepsy Type 1 | Narcolepsy Type 2Spain
-
University of Dublin, Trinity CollegeSt. James's Hospital, IrelandSuspendedNarcolepsy | Hypersomnolence | Narcolepsy Type 1 | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy | Narcolepsy 1 | Narcolepsy and HypersomniaIreland
-
Northwestern UniversityCompletedNarcolepsy | Narcolepsy Type 1 | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy | Narcolepsy Type 2United States
-
TakedaRecruitingNarcolepsy With Cataplexy | Narcolepsy Type 1 (NT1)United States, France, Germany, Netherlands, Switzerland
-
Vertex Pharmaceuticals IncorporatedNot yet recruitingNarcolepsy Type 1 (NT1)
-
University of UtahNot yet recruitingNightmare | Narcolepsy | Narcolepsy Type 1 | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy | Nightmare Disorder With Associated Other Sleep DisorderUnited States
-
Centessa Pharmaceuticals (UK) LimitedRecruitingNarcolepsy Type 1 | Narcolepsy Type 2United States
-
NLS PharmaceuticsCompletedNarcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With CataplexyUnited States
-
Centessa Pharmaceuticals (UK) LimitedRecruitingIdiopathic Hypersomnia | Narcolepsy Type 1 | Narcolepsy Type 2United States, Spain, Canada, France, Italy
-
Boston Children's HospitalAmerican Academy of Sleep MedicineCompletedIdiopathic Hypersomnia | Narcolepsy Type 1 | Narcolepsy Type 2United States
Clinical Trials on STAI (State-Trait Anxiety Inventory) Scale : Psychological inventory of 20 self-report items on a 4-point scale
-
Memorial Sloan Kettering Cancer CenterRecruitingCushing Syndrome | Cushing's Disease | Cushing DiseaseUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRecruitingCongenital Lung MalformationsFrance
-
University of FloridaFoundation for Physical Medicine and Rehabilitation; National Athletic Trainers...CompletedMusculoskeletal Injury TraumaUnited States
-
University of ValenciaUniversity of Alcala; Consorci Sanitari de Terrassa; Escoles Universitaries Gimbernat and other collaboratorsRecruitingMusculoskeletal PainSpain
-
University Hospital, Clermont-FerrandUnknownPostpartum Depression | Postpartum Hemorrhage | Postpartum Women | Postpartum Stress | Postpartum AnxietyFrance
-
University Hospital, ToulouseRecruitingCerebrovascular AccidentFrance
-
Zonguldak Bulent Ecevit UniversityCompletedAmerican Society of Anesthesiologists (ASA) I-II Risk Groups | the Follicular (Days 1-12 From Last Menstruation) or Luteal (Days 20-24) Phase of the Menstrual Cycle | Aged 18-55Turkey (Türkiye)
-
Hadassah Medical OrganizationRecruitingHealthy VolunteersIsrael